Inaktiver Wert

Biondvax Pharmaceuticals Ltd Aktie

Aktien

Schlusskurs TEL AVIV STOCK EXCHANGE Andere Börsenplätze
- ^ILa	-

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16.07.19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08.07.19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26.06.19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18.06.19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10.06.19

Manager	Titel	Alter	Seit
Amir Reichman CEO	Chief Executive Officer	49	02.03.21
Uri Ben-Or DFI	Director of Finance/CFO	52	01.01.07
Dalit Weinstein Fischer CTO	Chief Tech/Sci/R&D Officer	-	01.01.22

Aufsichtsräte	Titel	Alter	Seit
Adi Raviv BRD	Director/Board Member	69	24.03.20
Samuel Moed BRD	Director/Board Member	62	24.03.20
Morris Laster BRD	Director/Board Member	60	27.11.17

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+25.69%	47.86 Mrd.
LONZA GROUP AG	+46.90%	41.42 Mrd.
IQVIA HOLDINGS INC.	-3.46%	40.66 Mrd.
CELLTRION, INC.	-6.20%	28.92 Mrd.
ICON PUBLIC LIMITED COMPANY	+9.17%	25.55 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.27 Mrd.
BIO-TECHNE CORPORATION	+0.17%	12.15 Mrd.
MEDPACE HOLDINGS, INC.	+28.07%	12.14 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.99 Mrd.